Effect and clinical efficacy of Ginkgo biloba tablets on fibroblast growth factor 4 in patients with unstable angina pectoris
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 9
Abstract
Objective To explore the therapeutic effect of Ginkgo biloba tablets on patients with unstable angina and their impact on fibroblast growth factor 4 (FGF-4). Methods From January 2022 to September 2023, 360 patients with unstable angina who received treatment in Lianyungang First People's Hospital were selected and divided into low-risk group (Gensini score 1-30, n=112), medium risk group (Gensini score 31-60, n=156), and high-risk group (Gensini score 61-90, n=92) based on Gensini score. Each group of patients were randomly divided into an observation group and a control group. The control group was treated with standard treatment plan for coronary heart disease, while the observation group was treated with Ginkgo biloba tablets in addition to the control group. After 4 weeks of treatment, the levels of FGF-4 and inflammatory factors, the frequency and duration of angina attacks, and the severity of unstable angina (Braunwald classification) were compared between the different groups. Results After treatment, the peripheral serum FGF-4 levels of patients in the low-risk observation group and the medium risk observation group were higher than their corresponding control groups (P<0.05). The high-risk observation group showed an increasing trend in FGF-4 levels compared to its control group, but the difference was not statistically significant (P>0.05). The average levels of tumor necrosis factor (TNF)-α, interleukin (IL)-2, and IL-6 in the three observation groups were lower than those in the corresponding control group (P<0.05). After treatment, the frequency and duration of angina attacks in the low-risk observation group and the medium risk observation group were lower than those in the corresponding control group (P<0.05), while there was no statistically significant difference between the high-risk observation group and its control group (P>0.05). There was no statistically significant difference in the incidence of adverse reactions between the observation group and the control group after treatment (P>0.05). Conclusion Ginkgo biloba leaves extract tablets can improve the clinical efficacy and alleviate clinical symptoms in patients with unstable angina pectoris. Its mechanism may be related to its anti-inflammatory effect by increasing FGF-4 levels, thereby reducing the levels of TNF-α, IL-2, and IL-6 inflammatory factors.
Authors and Affiliations
SUN Xuechun , LI Gonghao, PENG Zhongxing, YIN Delu, ZHAO Yunfeng
Progress in Chinese medicine treatment of gastrointestinal dysfunction after gastric cancer surgery
Surgery is the most important method for the treatment of gastric cancer, but a series of complications will occur after gastric cancer surgery, the most common complication is gastrointestinal dysfunction, affecting the...
Preliminary construction of a prediction model for HBV-related acute-on-chronic liver failure combined with acute kidney injury
<b>Objective</b> To establish a model that can predict the occurrence of acute kidney injury (AKI) in elderly patients with HBV-related acute-on-chronic liver failure (HBV-ACLF), and to conduct a preliminary evaluation...
Predictive value of dynamic assessment of thrombose-related factors in diabetic nephropathy patients for thrombotic risk
"<b>Methods</b> A retrospective study was conducted to select 98 patients with DN who were treated in Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine from January 2020 to September 2022. Follow-u...
Expression and clinical significance of PD-1, PD-L1 and tumor infiltrating lymphocytes in neuroblastoma
<b>Objective</b> To investigate the expression of programmed cell death protein 1(PD-1), programmed cell death 1 ligand 1 (PD-L1) and tumor infiltrates lymphocytes (TIL) density in neuroblastoma and the relationship betw...
Analysis of risk factors of ineffective platelet transfusion for leukemia and the predictive value of HLA-Ⅰ antibody and TGF-β1
Objective To analyze the risk factors of ineffective platelet transfusion in leukemia, and explore the predictive value of human leukocyte antigen (HLA)-Ⅰ antibody and transforming growth factor-β1 (TGF-β1) for ineffect...